NIAGEN BIOSCIENCE INC (NAGE) — insider trading
Consumer Staples · NASDAQ
NIAGEN BIOSCIENCE INC (NAGE) has 13 reported SEC Form 4 insider transactions in our data (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Fried Robert N | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 1,106 | $2.71 | $3.0K | Form 4 |
| 2026-06-30 | Pamir Ozan | Officer (Chief Financial Officer) | Grant / award / vesting | 4,255 | $2.71 | $11.5K | Form 4 |
| 2026-06-30 | Lopez Carlos Luis | Officer (SVP, General Counsel) | Grant / award / vesting | 2,314 | $2.71 | $6.3K | Form 4 |
| 2026-06-24 | Jaksch Frank L Jr | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | Rubin Steven D | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | Shahbazi Hamed | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | Patrick Kristin | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | Cohen Ann | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | Ng Wang Yu Gary | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-06-24 | YU Wing Tak Wendy | Director | Grant / award / vesting (derivative) | 31,746 | — | $0 | Form 4 |
| 2026-04-24 | Fried Robert N | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-04-24 | Fried Robert N | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 20,000 | $2.61 | $52.2K | Form 4 |
| 2026-02-19 | Lopez Carlos Luis | Officer (SVP, General Counsel) | Grant / award / vesting (derivative) | 41,420 | — | $0 | Form 4 |
Ask the chat about NAGE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NIAGEN BIOSCIENCE INC (NAGE).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.